Oral bioavailability of silymarin formulated as a novel 3-day delivery system based on porous silica nanoparticles.

Xia Cao,Min Fu,Liang Wang,Hongfei Liu,Wenwen Deng,Rui Qu,Weiyan Su,Yawei Wei,Ximing Xu,Jiangnan Yu

DOI: https://doi.org/10.1016/j.actbio.2012.02.011

IF: 10.633

2012-01-01

Acta Biomaterialia

Abstract:The purpose of this study was to develop porous silica nanoparticles (PSNs) as a carrier to improve oral bioavailability of poorly water-soluble drugs, using silymarin as a model. PSNs were synthesized by reverse microemulsion and ultrasonic corrosion methods. A 3-day release formulation consisting of a silymarin solid dispersion, a hydrophilic gel matrix and silymarin-loaded PSNs was prepared. In vitro release studies indicated that both the silymarin-loaded PSNs and the 3-day release formulation showed a typical sustained-release pattern over a long period, about 72h. The in vivo studies revealed that the 3-day release formulation gave a significantly higher plasma concentration and larger area under the concentration–time curves than commercial tablets when orally administered to beagle dogs. This implies that the prepared 3-day release formulation significantly enhanced the oral bioavailability of silymarin, suggesting that PSNs can be used as promising drug carriers for oral sustained release systems. Thus providing a technically feasible approach for improving the oral bioavailability and long-term efficacy of poorly soluble drugs.